SANDOZ ABIRATERONE

Sandoz Canada, Inc.🇨🇦 Health Canada

Approval Id: bc4c4115e7ef92f1
Drug Approval Canada Name: SANDOZ ABIRATERONE
Product Name: SANDOZ ABIRATERONE
Status: Marketed
Status Date: 2021-01-18
Original Market Date: 2021-01-18
Din: 02486393
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L02BX03 ABIRATERONE
Atc Name: l 02 bx 03
Aig Number: 0152948001
Company Name: Sandoz Canada, Inc.
Company Address: 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path: /organization/sandoz-canada-inc

ABIRATERONE ACETATE

250 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

bc4c4115e7ef92f1

Type

Standard